Drug Information

Drug General Information
Drug ID
D0C6VV
Former ID
DCL001125
Drug Name
Prolarix
Synonyms
Prolarix (TN)
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 2 [522427]
Therapeutic Class
Anticancer Agents
Company
Protherics
Formula
C8H11N3O2
Canonical SMILES
C1C=CN(C=C1C(=O)N)CC(=O)N
InChI
1S/C8H11N3O2/c9-7(12)5-11-3-1-2-6(4-11)8(10)13/h1,3-4H,2,5H2,(H2,9,12)(H2,10,13)
InChIKey
WEJRSYKFMCUCRQ-UHFFFAOYSA-N
PubChem Compound ID
403128
PubChem Substance ID
534303, 11444956, 11566832, 15147337, 35564134, 51427958, 103088956, 103155631, 104591224, 117569620, 129569544, 134338866, 135252704, 137249657, 160677330, 162890133, 198979262, 232258944
Target and Pathway
Target(s) NRH dehydrogenase [quinone] 2 Target Info Inhibitor [550543]
References
Ref 522427ClinicalTrials.gov (NCT00746590) Study of Anti-tumour Effects and Safety of Prolarix in Hepatocellular Carcinoma. U.S. National Institutes of Health.
Ref 550543CenterWatch. Drugs in Clinical Trials Database. CenterWatch. 2008.